Pulmocide raises $30m for inhaled anti-infectivesA UK biotech company has raised $30 million to fund development of its treatments for respiratory infections. Privately-held Share XPulmocide raises $30m for inhaled anti-infectiveshttps://pharmaphorum.com/news/pulmocide-raises-30m-inhaled-anti-infectives/
